Literature DB >> 25011246

[Subacute toxicity and chemical analysis of Tibetan medicine Oxytropis falcata].

Xiao-Jing Zhang, Wei-Xia Liu, Peng Wei, Norbo Kelsang, Sheng Que, Liang Zhang, Qing-Ying Zhang.   

Abstract

Four different extracts of Oxytropis falcata, including the aerial aqueous extract, and the underground aqueous extract, the aerial lipophilic extract, and the underground lipophilic extract were prepared and then administrated orally to mice at the maximum dose (50 g x kg(-1) x d(-1) calculated by raw material) for fifteen days respectively. Compared with the control group, which was administrated of 1.0% tween-80, the treatment groups did not show significant differences in appearance and behavior. However, the organcoefficient, blood biochemical indicator and pathological section results showed that the lipophilic extracts of the aerial and underground parts of O. flacata showed mild injury to the liver of mice, while the aerial and underground aqueous extracts and the underground lipophilic extract showed mild toxicity to the kidney of male mice. Chemical analysis showed that the lipophilic extracts of the aerial and underground parts, especially aerial lipophilic extract, consisted of large amount of flavonoid aglycones with little amount of polysaccharides and proteins, while the aqueous extracts contained much polysaccharides and proteins with almost no flavonoid aglycones detected.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25011246

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  2 in total

1.  Therapeutic Effect and Mechanism of Oxytropis falcata Gel on Deep Second-Degree Burn in Rats.

Authors:  Xiao-Feng Lin; Kai-Jie Chen; He-Kun Shi; Le Yu; Jin-Shan Chen; Yan Fei
Journal:  Evid Based Complement Alternat Med       Date:  2017-11-13       Impact factor: 2.629

2.  Total Flavonoids Extracted from Oxytropis falcata Bunge Improve Insulin Resistance through Regulation on the IKKβ/NF-κB Inflammatory Pathway.

Authors:  Lixia Yang; Zhicheng Wang; Liangen Jiang; Wen Sun; Qiang Fan; Tonghua Liu
Journal:  Evid Based Complement Alternat Med       Date:  2017-03-26       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.